Fundz
New|Fundz now works inside Claude2 min

Finding your next opportunity shouldn’t require piecing together multiple databases, alerts and research tools.

Fundz combines its own funding and M&A intelligence with hiring, leadership and other business signals into one connected view of each company, ranks opportunities against your ideal customer profile, and delivers the evidence and verified contacts to act on. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Tsumura completes acquisition of Yomeishu Seizo

PRIVATEOct 07, 2026

Acquiring Company

Tsumura &

Acquired Company

Yomeishu Seizo

TokyoJapanBiotechnologyPharmaceuticalHealth CareNutrition

Description

Tsumura & Co. has successfully acquired Yomeishu Seizo for JPY 6.8 billion, finalizing the deal on September 1, 2026. The acquisition aims to boost Tsumura's healthcare portfolio, integrating Yomeishu's products into Tsumura's operations. The financial effects of this acquisition will begin to reflect in Tsumura's consolidated results from Q2 of fiscal year 2027. This strategic move is designed to enhance Tsumura's growth in the healthcare market.

Company Information

Company

Tsumura &

Location

Tokyo, Japan

About

Tsumura & Co. operates in the pharmaceutical industry, focusing on the production and wholesale of traditional Chinese medicine. The company is listed on the TSE Prime Market and is known for its traditional Chinese drug pieces and related services.

Fundz sees it the moment Tsumura & makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Tsumura &'s next move

Learn about Strategic plan

Frequently asked

Who acquired Yomeishu Seizo?

Yomeishu Seizo was acquired by Tsumura &, based in Tokyo. The deal was reported on October 7, 2026. Tsumura & Co. operates in the pharmaceutical industry, focusing on the production and wholesale of traditional Chinese medicine. Tsumura & is privately held and operates in Biotechnology.

When did Tsumura & acquire Yomeishu Seizo?

Tsumura &'s acquisition of Yomeishu Seizo was reported on October 7, 2026. Tsumura & Co. has successfully acquired Yomeishu Seizo for JPY 6.8 billion, finalizing the deal on September 1, 2026. The acquisition aims to boost Tsumura's healthcare portfolio, integrating Yomeishu's products into Tsumura's operations. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Yomeishu Seizo do?

Yomeishu Seizo is a company involved in the production of health beverages under the traditional Japanese medicinal philosophies. It focuses on research and development to create products that promote wellness and health. It is privately held, operating in Health Care, and is based in Japan.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.